Home Cart 0 Sign in  

[ CAS No. 313546-19-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 313546-19-9
Chemical Structure| 313546-19-9
Structure of 313546-19-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 313546-19-9 ]

Related Doc. of [ 313546-19-9 ]

Alternatived Products of [ 313546-19-9 ]

Product Details of [ 313546-19-9 ]

CAS No. :313546-19-9 MDL No. :MFCD18394417
Formula : C8H8BNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :FBHYTUYMTRDCOI-UHFFFAOYSA-N
M.W : 160.97 Pubchem ID :22591273
Synonyms :

Calculated chemistry of [ 313546-19-9 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 45.95
TPSA : 64.25 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.64 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 0.91
Log Po/w (WLOGP) : -0.45
Log Po/w (MLOGP) : -0.03
Log Po/w (SILICOS-IT) : -0.32
Consensus Log Po/w : 0.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.72
Solubility : 3.1 mg/ml ; 0.0193 mol/l
Class : Very soluble
Log S (Ali) : -1.84
Solubility : 2.3 mg/ml ; 0.0143 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.75
Solubility : 2.86 mg/ml ; 0.0178 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.95

Safety of [ 313546-19-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 313546-19-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 313546-19-9 ]

[ 313546-19-9 ] Synthesis Path-Downstream   1~8

  • 1
  • [ 444721-66-8 ]
  • [ 313546-19-9 ]
  • [ 760206-09-5 ]
YieldReaction ConditionsOperation in experiment
In 2-[(7bR,11aS)-1,2,7b,8,9,10,11,11a-octahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indol-6-yl]benzaldehyde, trifluoroacetic Acid Salt; Example 24 3-[(7bR,11aS)-1,2,7b,8,9,10,11,11a-octahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indol-6-yl]-2-methylbenzonitrile, Trifluoroacetic Acid Salt Using <strong>[313546-19-9]2-methyl-3-cyanophenyl boronic acid</strong> and following the procedures in EXAMPLE 7, tert-butyl (7bR,11aS)-6-bromo-1,2,7b,10,11,11a-hexahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indole-9(8H)-carboxylate was converted into the title compound of EXAMPLE 24. 1H NMR (CDCl3): delta 9.50 (broad s, 1H), 9.25 (broad s, 1H), 7.60-7.55 (m, 1H), 7.39-7.34 (m, 1H), 7.28 (t, 1H, J=7.7 Hz), 6.88 (s, 1H), 6.84 (d, 1H, J=1.5 Hz), 3.81 (ABq, 2H, JAB=15.7 Hz), 3.63-3.50 (m, 3H), 3.38-3.10 (m, 4H), 2.93-2.85 (m, 1H), 2.2.75-2.63 (m, 1H), 2.44 (s, 3H), 2.35-2.18 (m, 3H). LRMS (ES+) 362.3 (M+H)+.
In 2-[(7bR,11aS)-1,2,7b,8,9,10,11,11a-octahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indol-6-yl]benzaldehyde, trifluoroacetic Acid Salt; Example 24 3-[(7bR,11aS)-1,2,7b,8,9,10,11,11a-octahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indol-6-yl]-2-methylbenzonitrile, trifluoroacetic acid salt Using <strong>[313546-19-9]2-methyl-3-cyanophenyl boronic acid</strong> and following the procedures in EXAMPLE 7, tert-butyl (7bR,11aS)-6-bromo-1,2,7b,10,11,11a-hexahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indole-9(8H)-carboxylate was converted into the title compound of EXAMPLE 24. 1H NMR (CDCl3): delta 9.50 (broad s, 1H), 9.25 (broad s, 1H), 7.60-7.55 (m, 1H), 7.39-7.34 (m, 1H), 7.28 (t, 1H, J=7.7 Hz), 6.88 (s, 1H), 6.84 (d, 1H, J=1.5 Hz), 3.81 (ABq, 2H, JAB=15.7 Hz), 3.63-3.50 (m, 3H), 3.38-3.10 (m, 4H), 2.93-2.85 (m, 1H), 2.2.75-2.63 (m, 1H), 2.44 (s, 3H), 2.35-2.18 (m, 3H). LRMS (ES+): 362.3 (M+H)+.
  • 2
  • [ 313546-19-9 ]
  • [ 1005-37-4 ]
  • [ 1612182-09-8 ]
YieldReaction ConditionsOperation in experiment
With tetrakis(triphenylphosphine) palladium(0); potassium carbonate; In 1,4-dioxane; water; at 90℃;Sealed tube; Example 2583-[2-am ino-6-(methylamino)pyrimidin-4-yl]-2-methylbenzonitrile.A mixture of <strong>[1005-37-4]6-chloro-4-N-methylpyrimidine-2,4-diamine</strong> (24 mg, 0.15 mmol), (3-cyano-2-methylphenyl)boronic acid (29 mg, 0.18 mmol), potassium carbonate (41mg, 0.30 mmol) and palladium tetrakis(triphenylphosphine)palladium (0) (9 mg,0.008 mmol) in 1 ,4-dioxane (3 mL) and water (1 mL) was heated in a sealed tube at 900C overnight. The reaction mixture was concentrated and purified by preparative H PLC. LCMS [M+H] 240.
With tetrakis(triphenylphosphine) palladium(0); potassium carbonate; In 1,4-dioxane; water; at 90℃;Sealed tube; Example 258 3-[2-amino-6-(methylamino)pyrimidin-4-yl]-2-methylbenzonitrile. A mixture of <strong>[1005-37-4]6-chloro-4-N-methylpyrimidine-2,4-diamine</strong> (24 mg, 0.15 mmol), (3- cyano-2-methylphenyl)boronic acid (29 mg, 0.18 mmol), potassium carbonate (41 mg, 0.30 mmol) and palladium tetrakis(triphenylphosphine)palladium (0) (9 mg, 0.008 mmol) in 1 ,4-dioxane (3 mL) and water (1 mL) was heated in a sealed tube at 90C overnight. The reaction mixture was concentrated and purified by preparative HPLC. LCMS [M+H]+ 240.
  • 3
  • [ 16400-72-9 ]
  • [ 313546-19-9 ]
  • 3-(2-heptyl-6-oxo-3,6-dihydro-2H-pyran-4-yl)-2-methylbenzonitrile [ No CAS ]
  • 4
  • [ 16400-72-9 ]
  • [ 313546-19-9 ]
  • 3-(2-heptyl-6-oxotetrahydro-2H-pyran-4-yl)-2-methylbenzonitrile [ No CAS ]
  • 5
  • [ 313546-19-9 ]
  • 5,6-bis(3,5-dimethylphenyl)pyrazin-2-yl trifluoromethanesulfonic acid [ No CAS ]
  • 5-(3-cyano-2-methylphenyl)-2,3-bis(3,5-dimethylphenyl)pyrazine [ No CAS ]
YieldReaction ConditionsOperation in experiment
80% With potassium phosphate; tris-(dibenzylideneacetone)dipalladium(0); tris(2,6-dimethoxyphenyl)phosphine; In water; toluene; for 7.5h;Inert atmosphere; First, 2.15 g of 5,6-bis(3,5-dimethylphenyl)pyrazin-2-yl trifluoromethanesulfonate, 0.95 g of <strong>[313546-19-9]3-cyano-2-methylphenylboronic acid</strong>, 3.76 g of tripotassium phosphate, 40 mL of toluene, and 4.0 mL of water were put into a three-neck flask, and the air in the flask was replaced with nitrogen. The mixture in the flask was degassed by being stirred under reduced pressure, 0.045 g of tris(dibenzylideneacetone)dipalladium(0) and 0.087 g of tris(2,6-dimethoxyphenyl)phosphine were added thereto, and the mixture was refluxed for 7.5 hours. After a certain period of time, extraction was performed with toluene. Then, purification by silica gel column chromatography using hexane: ethyl acetate = 5: 1 (volume ratio) as a developing solvent was performed, so that 1.57 g of a target pyrazine derivative Hdmdppr-m3CP (abbreviation) (white solid) was obtained in a yield of 80 %. Synthesis Scheme (e-l) of Step 1 is shown below.
  • 6
  • [ 313546-19-9 ]
  • 5,6‐bis(3‐tert‐butyl‐5‐methylphenyl)pyrazin‐2‐yl trifluoromethanesulfonate [ No CAS ]
  • 5-(3-cyano-2-methylphenyl)-2,3-bis(3-tert-butyl-5-methylphenyl)pyrazine [ No CAS ]
YieldReaction ConditionsOperation in experiment
93% With potassium phosphate; tris-(dibenzylideneacetone)dipalladium(0); tris(2,6-dimethoxyphenyl)phosphine; In toluene; for 7.0h;Inert atmosphere; Reflux; Next, 1.84 g of 2,3-bis(3-tert-butyl-5-methylphenyl)-5-trifluoromethanesulfonate pyrazine obtained in step 2 above,0.68g of 3-cyano-2-methylphenylboronic acid, 2.71g of tripotassium phosphate,Put 28mL of toluene and 2.8mL of water into a 200mL three-necked flask,Replace the air in the flask with nitrogen.By stirring in the flask under reduced pressure,For degassing,Then add 0.032g of tris(dibenzylideneacetone)dipalladium(0) (abbreviation: Pd2(dba)3)And 0.062g of tris(2,6-dimethoxyphenyl)phosphine (abbreviation: (2,6-MeOPh)3P),Reflux for 7 hours.After the specified time has elapsed, toluene is used for extraction.Then, it was purified by silica gel column chromatography with hexane:ethyl acetate=10:1 (volume ratio) as the developing solvent,In order to obtain the desired pyrazine derivative HtBumdppr-m3CP (yellow-white solid, the yield is 1.62 g, the yield is 93%).The synthesis scheme of step 3 is shown below.
93% With potassium phosphate; tris-(dibenzylideneacetone)dipalladium(0); tris(2,6-dimethoxyphenyl)phosphine; In water; toluene; for 7.0h;Inert atmosphere; Reflux; Next, 1.84 g of 2,3-bis(3-tert-butyl-5-methylphenyl)-5-triflatepyrazine obtained in Step 2, 0.68 g of 3-cyano-2-methylphenylboronic acid, 2.71 g of tripotassium phosphate, 28 mL of toluene, and 2.8 mL of water were put into a 200 mL three-neck flask, and the atmosphere in the flask was replaced with nitrogen. The mixture in the flask was degassed by being stirred under reduced pressure, 0.032 g of tris(dibenzylideneacetone)dipalladium(0) (abbreviation: Pd2(dba)3) and 0.062 g of tris(2,6-dimethoxyphenyl)phosphine (abbreviation: (2,6-MeOPh)3P) were added thereto, and the mixture was refluxed for seven hours. After a predetermined time elapsed, extraction was performed with toluene. Then, purification by silica gel column chromatography using hexane and ethyl acetate as a developing solvent in a volume ratio of 10:1 was performed, so that 1.62 g of a target pyrazine derivative HtBumdppr-m3CP (yellowish white solid) was obtained in a yield of 93%. The synthesis scheme of Step 3 is shown below.
  • 7
  • [ 313546-19-9 ]
  • [ 502145-18-8 ]
  • 3-(2-aminothiazol-4-yl)-2-methyl-benzonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
With bis(tri-t-butylphosphine)palladium(0); potassium carbonate; In 1,4-dioxane; water; at 80℃;Inert atmosphere; Bis(tri-te/f-butylphosphine)palladium(0) (29 mg, 0.06 mmol) was added to a degassed solution of 4-bromothiazol-2-amine (100 mg, 0.56 mmol), (3-cyano-2-methyl- phenyl)boronic acid (180 mg, 1.12 mmol) and potassium carbonate (154 mg, 1.12 mmol) in 1 ,4-dioxane (4 ml_) and water (0.8 ml_). The flask was evacuated and backfilled with nitrogen (x 3) and the reaction mixture was stirred at 80 C overnight. The resulting mixture was allowed to cool to room temperature and was partitioned between EtOAc and 70% brine. The organic layer was separated, washed with 70% brine, dried over Na2SC>4 and concentrated in vacuo. Purification by chromatography on silica eluting with a gradient of 2 to 5% MeOH in DCM afforded a brown solid which was triturated with Et2 (1683) 1H NMR (500 MHz, DMSO-d6) d 7.81 (d, J = 7.8 Hz, 1H), 7.74 (d, J = 7.6 Hz, 1H), 7.41 (t, J = 7.7 Hz, 1 H), 7.11 (s, 2H), 6.76 (s, 1H), 2.60 (s, 3H).
With bis(tri-t-butylphosphine)palladium(0); potassium carbonate; In 1,4-dioxane; water; at 80℃;Inert atmosphere; Bis(tri-te/f-butylphosphine)palladium(0) (29 mg, 0.06 mmol) was added to a degassed solution of 4-bromothiazol-2-amine (100 mg, 0.56 mmol), (3-cyano-2-methyl- phenyl)boronic acid (180 mg, 1.12 mmol) and potassium carbonate (154 mg, 1.12 mmol) in 1 ,4-dioxane (4 ml_) and water (0.8 ml_). The flask was evacuated and backfilled with nitrogen (x 3) and the reaction mixture was stirred at 80 C overnight. The resulting mixture was allowed to cool to room temperature and was partitioned between EtOAc and 70% brine. The organic layer was separated, washed with 70% brine, dried over Na2SC>4 and concentrated in vacuo. Purification by chromatography on silica eluting with a gradient of 2 to 5% MeOH in DCM afforded a brown solid which was triturated with Et2 (1683) 1H NMR (500 MHz, DMSO-d6) d 7.81 (d, J = 7.8 Hz, 1H), 7.74 (d, J = 7.6 Hz, 1H), 7.41 (t, J = 7.7 Hz, 1 H), 7.11 (s, 2H), 6.76 (s, 1H), 2.60 (s, 3H).
  • 8
  • [ 313546-19-9 ]
  • 3-(2-amino-5-bromo-thiazol-4-yl)-2-methyl-benzonitrile [ No CAS ]
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 313546-19-9 ]

Organoboron

Chemical Structure| 138642-62-3

[ 138642-62-3 ]

(2-Cyanophenyl)boronic acid

Similarity: 0.98

Chemical Structure| 126747-14-6

[ 126747-14-6 ]

4-Cyanophenylboronic acid

Similarity: 0.91

Chemical Structure| 867333-43-5

[ 867333-43-5 ]

(5-Cyano-2-methylphenyl)boronic acid

Similarity: 0.90

Chemical Structure| 150255-96-2

[ 150255-96-2 ]

3-Cyanophenylboronic acid

Similarity: 0.90

Chemical Structure| 313546-18-8

[ 313546-18-8 ]

(4-Cyano-2-methylphenyl)boronic acid

Similarity: 0.90

Aryls

Chemical Structure| 138642-62-3

[ 138642-62-3 ]

(2-Cyanophenyl)boronic acid

Similarity: 0.98

Chemical Structure| 126747-14-6

[ 126747-14-6 ]

4-Cyanophenylboronic acid

Similarity: 0.91

Chemical Structure| 867333-43-5

[ 867333-43-5 ]

(5-Cyano-2-methylphenyl)boronic acid

Similarity: 0.90

Chemical Structure| 150255-96-2

[ 150255-96-2 ]

3-Cyanophenylboronic acid

Similarity: 0.90

Chemical Structure| 313546-18-8

[ 313546-18-8 ]

(4-Cyano-2-methylphenyl)boronic acid

Similarity: 0.90

Nitriles

Chemical Structure| 138642-62-3

[ 138642-62-3 ]

(2-Cyanophenyl)boronic acid

Similarity: 0.98

Chemical Structure| 126747-14-6

[ 126747-14-6 ]

4-Cyanophenylboronic acid

Similarity: 0.91

Chemical Structure| 867333-43-5

[ 867333-43-5 ]

(5-Cyano-2-methylphenyl)boronic acid

Similarity: 0.90

Chemical Structure| 150255-96-2

[ 150255-96-2 ]

3-Cyanophenylboronic acid

Similarity: 0.90

Chemical Structure| 313546-18-8

[ 313546-18-8 ]

(4-Cyano-2-methylphenyl)boronic acid

Similarity: 0.90